Skip to main content

Kyivstar Group Ltd. Announces Pricing of Secondary Offering of Common Shares

NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) — Kyivstar Group Ltd. (Nasdaq: KYIV; KYIVW) (“Kyivstar” or the “Company”), Ukraine’s leading digital operator, today announced the pricing of the public offering of 12,500,000 common shares (the “Offering”) by VEON Amsterdam B.V., the principal shareholder of the Company, and certain other selling shareholders (collectively, the “Selling Shareholders”) at a public offering price of USD 10.50 per share. The Company is not selling any common shares in the Offering. In connection with the Offering, the Selling Shareholders have granted the underwriters a 30-day option to purchase up to an additional 1,875,000 common shares at the public offering price, less underwriting discounts and commissions. The Offering is expected to close on February 2, 2026, subject to customary closing conditions. Morgan...

Continue reading

Kyivstar Announces Pricing of Secondary Offering of Common Shares Held by VEON

NEW YORK, New York, January 29, 2026 — VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or, together with its subsidiaries, the “VEON Group”) notes that Kyivstar Group Ltd. (Nasdaq: KYIV; KYIVW) (“Kyivstar” or the “Company”), Ukraine’s leading digital operator, today announced the pricing of the public offering of 12,100,000 common shares held by VEON Amsterdam B.V., the principal shareholder of the Company, and 400,000 common shares held by certain other selling shareholders (collectively, the “Selling Shareholders”) at a public offering price of USD 10.50 per share (the “Offering”). In connection with the Offering, the Selling Shareholders have granted the underwriters a 30-day option to purchase up to an additional 1,875,000 common shares at the public offering price, less underwriting discounts and commissions. Kyivstar...

Continue reading

M EVO GLOBAL ACQUISITION CORP II Announces Pricing of Upsized $270 Million Initial Public Offering

New York, Jan. 29, 2026 (GLOBE NEWSWIRE) — M EVO GLOBAL ACQUISITION CORP II (the “Company”) announced today that it priced its initial public offering of 27,000,000 units at $10.00 per unit after upsizing the original offering of 22,500,000 units. The units will be listed on the Nasdaq Global Market (“Nasdaq”) and will trade under the ticker symbol “MEVOU” beginning January 30, 2026. Each unit consists of one Class A ordinary share of the Company, $0.0001 par value per share, and one-half of one redeemable warrant, each whole warrant entitling the holder to purchase one Class A ordinary share upon exercise, at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the Nasdaq under the symbols “MEVOX” and “MEVOW,”...

Continue reading

Muzero Acquisition Corp Announces the Pricing of $175 Million Initial Public Offering

New York, New York, Jan. 29, 2026 (GLOBE NEWSWIRE) — Muzero Acquisition Corp (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company today announced the pricing of its initial public offering of 17,500,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share. The units are expected to trade on the Global Market tier of The Nasdaq Stock Market LLC (“Nasdaq”) under the ticker symbol “MUZEU” beginning January 30, 2026. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate...

Continue reading

FireFly set to capitalise on strong copper outlook with economic studies underway

Preliminary Economic Assessment on Green Bay Copper-Gold Project on track for completion in the June 2026 quarter, highlighting the value of the world-scale Resource HIGHLIGHTSTotal Green Bay Mineral Resource increased to 50.4Mt @ 2.0% Copper Equivalent (CuEq) in the Measured & Indicated (M&I) categories plus 29.3Mt @ 2.5% CuEq in the Inferred category:This was a 51% increase from the previous Mineral Resource Estimate (MRE) of October 2024 Contained copper increased to 863kt M&I (+113%) plus 566kt Inferred Contained gold increased to 546koz M&I (+174%) plus 563koz Inferred (+62%) (see ASX announcement dated 18 November 2025)FireFly has established a high-grade core comprising 8.8Mt @ 3.9% CuEq in the M&I and 10.9Mt @ 3.8% CuEq in the Inferred categories, materially enhancing development options (see ASX...

Continue reading

authID and MajorKey Selected by Global Retailer to Deliver High-Assurance Identity Onboarding and Privileged Access Protection

   New customer win underscores authID’s leadership in workforce verification and stopping AI-driven hiring fraud across global enterprises  Denver, Jan. 29, 2026 (GLOBE NEWSWIRE) — authID (Nasdaq: AUID), a leading provider of biometric identity verification and authentication solutions, today announced that a global retailer of personal care products with more than $6B in annual sales has selected authID and technology partner MajorKey, an identity security organization and certified Microsoft services provider, to secure employee and contractor identity verification and protect privileged access to corporate IT systems for users from multiple third-party contractors across several countries.  Addressing the Growing Risk of Hiring Fraud and AI-Generated Impostors  With the onslaught of AI-generated profiles, state-sponsored fakes,...

Continue reading

Columbia Financial, Inc. Announces Promotion of Dennis E. Gibney to First Senior Executive Vice President and Chief Banking Officer

Thomas Splaine Jr. Appointed as Executive Vice President and Chief Financial Officer FAIR LAWN, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) — Columbia Financial, Inc. (the “Company”) (NASDAQ: CLBK), the mid-tier holding company for Columbia Bank (“Bank”), today announced that, effective immediately, Dennis E. Gibney, Senior Executive Vice President and Chief Financial Officer of the Company and the Bank, has been promoted to First Senior Executive Vice President and Chief Banking Officer of the Company and the Bank. In connection with Mr. Gibney’s promotion, effective immediately, Thomas Splaine, Jr., First Senior Vice President and Chief Accounting Officer of the Company and the Bank, has been appointed Executive Vice President and Chief Financial Officer of the Company and the Bank. In his new role, Mr. Gibney will partner closely with...

Continue reading

Hampton Closes Previously Announced Issue of Shares for Debt

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) — Hampton Financial Corporation (“Hampton” or the “Company”, TSXV: HFC) announces that it has closed the issuance of shares to settle certain debt obligations under debentures as described in Hampton’s press release of December 23, 2025. Hampton issued 10,528,141 subordinate voting shares to debenture holders to settle all obligations under Hampton debentures in the aggregate principal amount of $4 million, and to settle a quarterly interest payment under Hampton debentures in the aggregate principal amount of approximately $5.2 million. The subordinate voting shares are subject to a hold period of four months and one day from their date of issuance, which will expire on May 30, 2026. This closing will...

Continue reading

MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN‑166 (ibudilast) in ALS patients

LA JOLLA, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that as of the end of January 2026, 12 sites in the US are activated and 100 patients have been enrolled in the SEANOBI study (Scalable Expanded Access with Analysis of Neurofilament and Other Biomarkers in ALS; NCT 06743776) representing 50% of the planned 200-enrollment, evaluating MN‑166 (ibudilast) in patients with amyotrophic lateral sclerosis (ALS). Dr. Yuichi Iwaki, President and CEO of MediciNova, commented: “Achieving 100 enrolled patients in the NIH‑funded SEANOBI Expanded‑Access Program marks substantial progress in the clinical development of MN‑166. We are deeply grateful to the patients...

Continue reading

Newbridge Acquisition Limited Announces Pricing of $50 Million Initial Public Offering

HONG KONG, CHINA, Jan. 29, 2026 (GLOBE NEWSWIRE) — Newbridge Acquisition Limited (NASDAQ: NBRG) (the “Company”) announced today that it priced its initial public offering of 5,000,000 units at $10.00 per unit. The units are expected to be listed on the NASDAQ Capital Market (“NASDAQ”) and trade under the ticker symbol “NBRGU” beginning January 30, 2026. Each unit consists of one Class A ordinary share and one right. Each right entitles the holder thereof to receive one-eighth (1/8) of one Class A ordinary share upon the consummation of an initial business combination. No fractional rights will be issued upon separation of the units. As a result, eight rights are needed to receive one Class A ordinary share at the closing of the initial business combination. Once the securities comprising the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.